NCT01559883

Completed

Study on Thrombosis Therapy in German Cancer Patients

LEO Pharma Source

Other study identifiers

Sponsor study identifier

DE-Thrombose-NIS-2012

Study Type

observational

Actual enrollment (reported)

76

Locations

1 country

Sites

1

Timeline

Study Start

February 2012

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2013

Actual (reported)

Study Completion

December 2013

Actual (reported)

Brief Summary

The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 76 participants
Study completion date: December 2013
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2012
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
March 1, 2012
Actual (reported)
First Posted
March 21, 2012
Actual (reported)
Primary Completion
December 2013
Actual (reported)
Study Completion
December 2013
Actual (reported)

Last Updated: August 15, 2014
Status Verified: November 2013
Last Update Submitted: August 14, 2014

Conditions

Cancer Deep Vein Thrombosis Pulmonary Embolism

Keywords

cancerthrombosispulmonary embolismanticoagulationlow molecular weight heparin

Outcome Measures

Primary Outcomes (1)

treatment time on low molecular weight heparin
1 year

Secondary Outcomes (2)

patient pathways
1 year
risk factors for DVT
1 year

Study Arms (1)

all eligible patients

there is only 1 Cohort in which all patients participating in this NIS are included

Other: no intervention is being made

Interventions

no intervention is being madeOther

This is a Non-Interventional Study (NIS)

all eligible patients

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Cancer patient with acute deep vein throbosis/ pulmonary embolism in ambulatory oncology care/practice

You may qualify if:

patient with cancer and acute deep vein thrombosis and/or pulmonary embolism

You may not qualify if:

Sponsors & Collaborators

LEO Pharma
Industrylead

Study Sites (1)

Prof. Dr. Axel Matzdorff

Saarbrücken, Saarland, 66111, Germany

MeSH Terms

Conditions

NeoplasmsVenous ThrombosisPulmonary EmbolismThrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular DiseasesLung DiseasesRespiratory Tract DiseasesEmbolism

Study Officials

Axel Matzdorff, Prof.Dr.
Caritasklinikum Saarbrücken, St. Theresia
PRINCIPAL INVESTIGATOR

Enrollment

76 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 1, 2012

First Posted

March 21, 2012

Study Start

February 2012

Date type not reported

This date has not been verified as actual or estimated.

NCT01602432

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Withdrawn

NCT01602445

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Completed

NCT01542723

Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy

Not ApplicableCompleted

NCT01542762

Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation

Not ApplicableCompleted

NCT01780987

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Phase 3Completed

NCT01630148

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

Not ApplicableCompleted

life expectancy less that 6 months
age less that 18 years

Contact the study team to confirm eligibility.

Primary Completion

December 2013

Actual (reported)

Study Completion

December 2013

Actual (reported)

Last Updated

August 15, 2014

Record last verified: 2013-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01559883
Data provider: ClinicalTrials.gov
Source updated: 2014-08-15
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:35:21 UTC

Locations

DE(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

all eligible patients

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations